Milanetti, F <br/><br/>
Safety and immunogenicity of co-administered MF59-adjuvanted 2009 pandemic and plain 2009-10 seasonal influenza vaccines in rheumatoid arthritis patients on biologicals.  [electronic resource] 

 -  Clinical and experimental immunology  Jul 2014 
 - 287-94 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1365-2249 
<br/><br/><label>Standard No.: </label>10.1111/cei.12292  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abatacept<br/>Adjuvants, Immunologic--administration & dosage<br/>Adult<br/>Antirheumatic Agents--administration & dosage<br/>Arthritis, Rheumatoid--complications<br/>Biological Therapy<br/>Cytokines--metabolism<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunoconjugates--administration & dosage<br/>Influenza Vaccines--administration & dosage<br/>Influenza, Human--complications<br/>Italy<br/>Male<br/>Middle Aged<br/>Pandemics<br/>Polysorbates--administration & dosage<br/>Seasons<br/>Squalene--administration & dosage<br/>T-Lymphocytes--drug effects<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors